Quintessence continues with mesothelioma drug
On April 21 I reported that a Madison, Wisconsin-based biotechnology firm, Quintessence Bioscience, was moving forward on a drug similar to Alfacel’s Onconase, to treat mesothelioma. The report, from...
View ArticleArenegyr granted orphan drug status
Friday it was announced the European Commission has granted orphan drug status for Arenegyr, an anti-tumor therapeutic drug manufactured by MolMed S.p.A. in the treatment of malignant pleural...
View ArticleNew mesothelioma drug granted orphan status from EU
Drug maker Verastem Inc. has obtained approval from the European Commission to proceed with the development of a potential new mesothelioma treatment, which has been granted orphan status. Orphan...
View ArticleCOMMAND clinical trial treating patients with malignant pleural mesothelioma
Drug manufacturer Verastem, Inc., has initiated a registration-directed, double-blind, placebo-controlled clinical trial for patients with malignant pleural mesothelioma. The trial is a...
View Article
More Pages to Explore .....